• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

翻译后修饰与蛋白病:蛋白质组守护者是如何被击败的。

Posttranslational modifications and proteinopathies: how guardians of the proteome are defeated.

机构信息

Institut für Physiologische Chemie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Hollystr. 1, D-06114 Halle/Saale, Germany.

出版信息

Biol Chem. 2019 Jun 26;400(7):895-915. doi: 10.1515/hsz-2018-0458.

DOI:10.1515/hsz-2018-0458
PMID:30998500
Abstract

Protein folding is one of the fundamental processes in life and therefore needs to be tightly regulated. Many cellular quality control systems are in place to ensure that proteostasis is optimally adjusted for a changing environment, facilitating protein folding, translocation and degradation. These systems include the molecular chaperones and the major protein degradation systems, namely the ubiquitin proteasome system and autophagy. However, the capacity of the quality control systems can be exhausted and protein misfolding and aggregation, including the formation of amyloids, can occur as a result of ageing, mutations or exogenous influences. There are many known diseases in which protein misfolding and aggregation can be the underlying cause of the pathological condition; these are referred to as proteinopathies. Over the last decade, it has become clear that posttranslational modifications can govern and modulate protein folding, and that aberrant posttranslational modifications can cause or contribute to proteinopathies. This review provides an overview of protein folding and misfolding and the role of the major protein quality control systems. It focusses on different posttranslational modifications and gives examples of how these posttranslational modifications can alter protein folding and cause or accompany proteinopathies.

摘要

蛋白质折叠是生命中的基本过程之一,因此需要受到严格调控。许多细胞质量控制系统已经就位,以确保蛋白质稳态能够根据不断变化的环境进行最佳调整,促进蛋白质折叠、转运和降解。这些系统包括分子伴侣以及主要的蛋白质降解系统,即泛素蛋白酶体系统和自噬。然而,质量控制系统的能力可能会耗尽,蛋白质错误折叠和聚集,包括淀粉样蛋白的形成,可能会由于衰老、突变或外源性影响而发生。有许多已知疾病中,蛋白质错误折叠和聚集可能是病理状况的根本原因;这些疾病被称为蛋白质病。在过去十年中,已经清楚地认识到翻译后修饰可以控制和调节蛋白质折叠,并且异常的翻译后修饰可以导致或促成蛋白质病。本综述概述了蛋白质折叠和错误折叠以及主要蛋白质质量控制系统的作用。它聚焦于不同的翻译后修饰,并举例说明这些翻译后修饰如何改变蛋白质折叠并导致或伴随蛋白质病。

相似文献

1
Posttranslational modifications and proteinopathies: how guardians of the proteome are defeated.翻译后修饰与蛋白病:蛋白质组守护者是如何被击败的。
Biol Chem. 2019 Jun 26;400(7):895-915. doi: 10.1515/hsz-2018-0458.
2
When proteostasis goes bad: Protein aggregation in the cell.当蛋白质稳态失衡时:细胞内的蛋白质聚集
IUBMB Life. 2017 Feb;69(2):49-54. doi: 10.1002/iub.1597. Epub 2017 Jan 9.
3
Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.改善蛋白质错误折叠神经退行性疾病的潜在机制和化学/生化治疗方法。
Biofactors. 2017 Nov;43(6):737-759. doi: 10.1002/biof.1264. Epub 2016 Feb 22.
4
In vivo aspects of protein folding and quality control.蛋白质折叠和质量控制的体内方面。
Science. 2016 Jul 1;353(6294):aac4354. doi: 10.1126/science.aac4354.
5
Protein folding, misfolding and quality control: the role of molecular chaperones.蛋白质折叠、错误折叠与质量控制:分子伴侣的作用
Essays Biochem. 2014;56:53-68. doi: 10.1042/bse0560053.
6
[Proteinopathies--forms of neurodegenerative disorders with protein aggregation-based pathology].[蛋白质病——基于蛋白质聚集病理的神经退行性疾病形式]
Mol Biol (Mosk). 2012 May-Jun;46(3):402-15.
7
The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.热休克蛋白70(HSP70)及其共伴侣蛋白在蛋白质错误折叠、聚集和疾病中的作用。
Subcell Biochem. 2015;78:243-73. doi: 10.1007/978-3-319-11731-7_12.
8
Pathways of cellular proteostasis in aging and disease.细胞蛋白稳态在衰老和疾病中的途径。
J Cell Biol. 2018 Jan 2;217(1):51-63. doi: 10.1083/jcb.201709072. Epub 2017 Nov 10.
9
Protein folding and misfolding in the neurodegenerative disorders: a review.神经退行性疾病中的蛋白质折叠与错误折叠:综述
Rev Neurol (Paris). 2014 Mar;170(3):151-61. doi: 10.1016/j.neurol.2013.11.002. Epub 2014 Mar 7.
10
Walking the tightrope: proteostasis and neurodegenerative disease.走钢丝:蛋白质稳态与神经退行性疾病
J Neurochem. 2016 May;137(4):489-505. doi: 10.1111/jnc.13575. Epub 2016 Mar 8.

引用本文的文献

1
Proteome solubility is differentially reshaped by thermal stress and regulators of ubiquitination.蛋白质组的溶解度因热应激和泛素化调节剂而发生不同程度的重塑。
J Biol Chem. 2025 Jul 24;301(9):110517. doi: 10.1016/j.jbc.2025.110517.
2
Proteins with cognition-associated structural changes in a rat model of aging exhibit reduced refolding capacity.在衰老大鼠模型中具有认知相关结构变化的蛋白质表现出降低的重折叠能力。
Sci Adv. 2025 Jul 11;11(28):eadt3778. doi: 10.1126/sciadv.adt3778.
3
'Intelligent' proteins.“智能”蛋白质。
Cell Mol Life Sci. 2025 Jun 14;82(1):239. doi: 10.1007/s00018-025-05770-1.
4
Non-enzymatic posttranslational protein modifications in protein aggregation and neurodegenerative diseases.蛋白质聚集和神经退行性疾病中的非酶促翻译后蛋白质修饰
RSC Chem Biol. 2024 Dec 19;6(2):129-149. doi: 10.1039/d4cb00221k. eCollection 2025 Feb 5.
5
Cognition-Associated Protein Structural Changes in a Rat Model of Aging are Related to Reduced Refolding Capacity.衰老大鼠模型中与认知相关的蛋白质结构变化与重折叠能力降低有关。
bioRxiv. 2024 Sep 24:2024.09.20.614172. doi: 10.1101/2024.09.20.614172.
6
The Delayed Turnover of Proteasome Processing of Myocilin upon Dexamethasone Stimulation Introduces the Profiling of Trabecular Meshwork Cells' Ubiquitylome.地塞米松刺激后肌球蛋白蛋白酶体加工的延迟翻转引入了小梁网细胞泛素组的分析。
Int J Mol Sci. 2024 Sep 17;25(18):10017. doi: 10.3390/ijms251810017.
7
Bio-Pathological Functions of Posttranslational Modifications of Histological Biomarkers in Breast Cancer.乳腺癌组织生物标志物翻译后修饰的生物病理功能。
Molecules. 2024 Sep 2;29(17):4156. doi: 10.3390/molecules29174156.
8
Pathogenesis and clinical features of severe hepatitis E virus infection.戊型肝炎病毒严重感染的发病机制及临床特征
World J Virol. 2024 Jun 25;13(2):91580. doi: 10.5501/wjv.v13.i2.91580.
9
Mass Spectrometry Strategies for -Glycoproteomics.用于糖蛋白质组学的质谱策略
Cells. 2024 Feb 25;13(5):394. doi: 10.3390/cells13050394.
10
Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies.利用新兴蛋白质组学技术将衰老治疗干预措施应用于临床
Biology (Basel). 2023 Oct 2;12(10):1301. doi: 10.3390/biology12101301.